Australians under the age of 50 are advised not to obtain the AstraZeneca COVID jab, which is the basis of the country’s vaccine deployment, after medical professionals have expressed concern about the problem of blood clots abroad.
This is based on advice from the Australian Immunization Technology Advisory Group (ATAGI) and recommends AstraZeneca to anyone over the age of 50.
At a snap press conference Thursday night, Prime Minister Scott Morrison said the group had met hours earlier Thursday and provided recommendations for the Australian population at 7 pm.
“At this time, Pfizer vaccines are preferred over AstraZeneca vaccines for adults under the age of 50 who have not received the first dose of AstraZeneca vaccine,” said Professor Paul Kelly, Chief Medical Officer.
“This is based on an increased risk of complications from COVID-19 with age, and thus an increased benefit of vaccination.
“The second recommendation is that vaccination providers should give the first dose of AstraZeneca COVID-19 vaccine only to adults under the age of 50 whose benefits clearly outweigh the risks of their individual situation. ..
“The third recommendation is that there are no serious adverse events and a second dose can be safely given to a person who has received a first dose of COVID-19 AstraZeneca.”
Professor Brendan Murphy of the Ministry of Health said the approach was “with great care” to ensure that Phase 1b healthcare workers under the age of 50 were prioritized with the Pfizer vaccine.
Health Minister Greg Hunt said the government would continue to follow medical advice as more evidence became available.
“If they advise on age restrictions and other variations, we do it, we adopt it,” Hunt said.
Morrison outlined why the vaccine deployment was changed, stating that “there is no place you want” in Australia’s “strong position without community infections”, and the government continues to “Australia” based on medical advice. Acted “for the best interests of the person.” ..
The move is similar to what was done in the UK, and the UK Vaccine Advisory Committee has replaced the Oxford-AstraZeneca vaccine where possible due to the rare side effect of “disappearing” blood clots in the brain. He advised that it should be given to children under the age of 30.
The impact of the decision on vaccine deployment is not yet widely known, given that it will have a significant impact on the general public who are told to receive the first jab in the middle of the year.
Vaccine advice updated for under 50s, with Pfizer recommended Source link Vaccine advice updated for under 50s, with Pfizer recommended